Doctor profile · Federal record

Dr. Katja Felsinger, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Endocrinology, Diabetes & Metabolism Physician · Melbourne, FL

  • NPI 1609839505
  • Accepts Medicare
  • 34 yrs in practice
  • Licensed in 2 states
  • Female
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1344 S Apollo Blvd Ste 2A
Melbourne, FL 329013183
(321) 727-2990
Mailing address
1344 S Apollo Blvd
Melbourne, FL 329013183

Credentials & registration

NPPES · NUCC
NPI registered
April 2006 — 20 yrs on file
Profile last updated
December 10, 2021
Year of graduation
1992 — 34 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State licenses (2)
Florida #ME146586 · West Virginia #20602

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1609839505. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
894
Distinct HCPCS
7
Medicare allowed
$92,191
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 580 200 $124
99213 Established patient office or other outpatient visit, 20-29 minutes 81 43 $87
95251 Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report 68 32 $34
82947 Blood glucose (sugar) level 63 45 $4
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month 50 12 $61
99204 New patient office or other outpatient visit, 45-59 minutes 34 34 $164
99203 New patient office or other outpatient visit, 30-44 minutes 18 18 $111

In context: peer comparison

Among 6 peers in Melbourne Endocrinology, Diabetes & Metabolism Physician, average services per provider: 442. This provider delivers 2.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$530
Transactions
30
Manufacturers
12
Payer (manufacturer) Industry Txns Amount
Amgen INC. 5 $76.26
Boehringer Ingelheim Pharmaceuticals, INC. 4 $70.18
Abbvie INC. 4 $70.08
Novo Nordisk INC 4 $59.26
Insulet Corporation 3 $53.06
Esperion Therapeutics, INC. 2 $48.17
Lilly USA, LLC 2 $36.74
Abbott Laboratories 2 $31.53
Alexion Pharmaceuticals, INC. 1 $24.90
Xeris Pharmaceuticals, INC. 1 $23.54
Medtronic, INC. 1 $20.26
Averitas Pharma INC. 1 $16.45

By nature of payment

Food and Beverage
$530

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
3,945
Patients
1,221
Total drug cost
$1,705,895
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 613 162 $11,844
Ozempic (Semaglutide) Brand 487 124 $712,696
Rosuvastatin Calcium Generic 431 156 $8,358
Metformin Hcl Generic 384 131 $3,859
Atorvastatin Calcium Generic 341 118 $5,204
Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) Brand 226 83 $208,392
Glimepiride Generic 214 66 $2,490
Farxiga (Dapagliflozin Propanediol) Brand 211 57 $257,969
Jardiance (Empagliflozin) Brand 190 55 $240,010
Trulicity (Dulaglutide) Brand 163 36 $244,988

Frequently asked questions

Auto-generated from federal data
What is Dr. Katja Felsinger's medical specialty?
Dr. Katja Felsinger practices Endocrinology, Diabetes & Metabolism Physician in Melbourne, FL.
Where does Dr. Katja Felsinger practice?
Dr. Katja Felsinger practices at 1344 S Apollo Blvd Ste 2A, Melbourne, FL 329013183. Office phone: 3217272990.
What is Dr. Katja Felsinger's NPI?
Dr. Katja Felsinger's National Provider Identifier (NPI) is 1609839505, issued by NPPES.
Does Dr. Katja Felsinger accept Medicare assignment?
Yes. Dr. Katja Felsinger accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Katja Felsinger commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99213); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.